GIP-(3–42) does not antagonize insulinotropic effects of GIP at physiological concentrations

Item

http://www.wikidata.org/entity/Q58448506

description

scientific article published on 11 April 2006

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2006

@uk

name

GIP-

@nl

GIP-(3–42) does not antagonize ...... t physiological concentrations

@en

type

Item

label

GIP-

@nl

GIP-(3–42) does not antagonize ...... t physiological concentrations

@en

prefLabel

GIP-

@nl

GIP-(3–42) does not antagonize ...... t physiological concentrations

@en

P1476

GIP-(3-42) does not antagonize ...... t physiological concentrations

@en

P2093

Astrid Plamboeck

http://www.w3.org/2001/XMLSchema#string

Jocelyn de Heer

http://www.w3.org/2001/XMLSchema#string

P2860

Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

Valine pyrrolidide preserves intact glucose-dependent insulinotropic peptide and improves abnormal glucose tolerance in minipigs with reduced beta-cell mass

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.

[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo.

Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans.

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.

Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo.

The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice.

P304

E468-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00577.2005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P50

Jens Juul Holst

Mette M. Rosenkilde

Carolyn F. Deacon

P577

2006-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16608883

http://www.w3.org/2001/XMLSchema#string